Posted by Michael Wonder on 20 Dec 2021
New treatment for heart failure to support thousands of Australian patients
20 December 2021 - From 1 January 2022, tens of thousands of Australians with symptomatic heart failure will have access to a new treatment option on the Pharmaceutical Benefits Scheme, saving lives and protecting lives across the nation.
The Morrison Government is expanding the listing of Forxiga (dapagliflozin) for the treatment of symptomatic heart failure.
